Stella Pharma announces first clinical trial on oncotherapy using boron neutron capture therapy (BNCT): partners are Sumitomo Heavy Industries and Kyoto University

Experiments are done at Kyoto University Research Reactor Institute’s Oncology Center

Stella Pharma press release, Sept. 6, 2012

Most popular posts: